FAD Prep/NAHEMS Guidelines
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Red List of Bangladesh Volume 2: Mammals
Red List of Bangladesh Volume 2: Mammals Lead Assessor Mohammed Mostafa Feeroz Technical Reviewer Md. Kamrul Hasan Chief Technical Reviewer Mohammad Ali Reza Khan Technical Assistants Selina Sultana Md. Ahsanul Islam Farzana Islam Tanvir Ahmed Shovon GIS Analyst Sanjoy Roy Technical Coordinator Mohammad Shahad Mahabub Chowdhury IUCN, International Union for Conservation of Nature Bangladesh Country Office 2015 i The designation of geographical entitles in this book and the presentation of the material, do not imply the expression of any opinion whatsoever on the part of IUCN, International Union for Conservation of Nature concerning the legal status of any country, territory, administration, or concerning the delimitation of its frontiers or boundaries. The biodiversity database and views expressed in this publication are not necessarily reflect those of IUCN, Bangladesh Forest Department and The World Bank. This publication has been made possible because of the funding received from The World Bank through Bangladesh Forest Department to implement the subproject entitled ‘Updating Species Red List of Bangladesh’ under the ‘Strengthening Regional Cooperation for Wildlife Protection (SRCWP)’ Project. Published by: IUCN Bangladesh Country Office Copyright: © 2015 Bangladesh Forest Department and IUCN, International Union for Conservation of Nature and Natural Resources Reproduction of this publication for educational or other non-commercial purposes is authorized without prior written permission from the copyright holders, provided the source is fully acknowledged. Reproduction of this publication for resale or other commercial purposes is prohibited without prior written permission of the copyright holders. Citation: Of this volume IUCN Bangladesh. 2015. Red List of Bangladesh Volume 2: Mammals. IUCN, International Union for Conservation of Nature, Bangladesh Country Office, Dhaka, Bangladesh, pp. -
Letter Bill 0..2
HB2554 *LRB10110502SLF55608b* 101ST GENERAL ASSEMBLY State of Illinois 2019 and 2020 HB2554 by Rep. Camille Y. Lilly SYNOPSIS AS INTRODUCED: 720 ILCS 5/48-11 Amends the Criminal Code of 2012. Provides that a person commits unlawful use of an exotic animal in a traveling animal act when he or she knowingly allows for the participation of an exotic animal (rather than an elephant) in a traveling animal act. This offense is a Class A misdemeanor. Defines "exotic animal". LRB101 10502 SLF 55608 b CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY A BILL FOR HB2554 LRB101 10502 SLF 55608 b 1 AN ACT concerning criminal law. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 5. The Criminal Code of 2012 is amended by changing 5 Section 48-11 as follows: 6 (720 ILCS 5/48-11) 7 Sec. 48-11. Unlawful use of an exotic animal elephant in a 8 traveling animal act. 9 (a) Definitions. As used in this Section: 10 "Exotic animal" means any animal that is native to a 11 foreign country or of foreign origin or character, is not 12 native to the United States, or was introduced from abroad 13 including, but not limited to, lions, tigers, leopards, 14 elephants, camels, antelope, anteaters, kangaroos, and water 15 buffalo and species of foreign domestic cattle, such as Ankole, 16 Gayal, and Yak or a wild animal. 17 "Mobile or traveling animal housing facility" means a 18 transporting vehicle such as a truck, trailer, or railway car 19 used to transport or house animals while traveling to an 20 exhibition or other performance. -
Antibody Response and Evaluation of Protection After Immunisation With
Aus dem Institut für Virologie der Tierärztlichen Hochschule Hannover Untersuchungen zur Wirksamkeitsprüfung und praktischen Anwendung von viralen Rinderimpstoffen [Investigations on the efficacy testing and practical application of viral cattle vaccines] Habilitationsschrift zur Erlangung der Venia legendi an der Tierärztlichen Hochschule Hannover Vorgelegt von Dr. med. vet. Birgit Makoschey Hannover 2009 Tag der nichtöffentlichen wissenschaftlichen Aussprache 15. Juni 2010 Table of contents Table of contents Table of contents.....................................................................................................................................3 Abbreviations..........................................................................................................................................4 List of used publications ........................................................................................................................6 A. Introduction...................................................................................................................................8 Vaccines in veterinary medicine.........................................................................................................8 Live attenuated vaccines .................................................................................................................8 Inactivated vaccines ........................................................................................................................9 Alternative approaches -
Vaccination As a Control Tool for Exotic Animal Diseases
www.defra.gov.uk Vaccination as a Control Tool for Exotic Animal Disease Key Considerations March 2010 Department for Environment, Food and Rural Affairs Nobel House 17 Smith Square London SW1P 3JR Tel: 020 7238 6000 Website: www.defra.gov.uk © Crown copyright 2010 Copyright in the typographical arrangement and design rests with the Crown. This publication (excluding the Royal Arms and departmental logos) may be re-used free of charge in any format or medium for research for non-commercial purposes, private study or for internal circulation within an organisation. This is subject to it being re-used accurately and not used in a misleading context. The material must be acknowledged as Crown copyright and the title of the publication specified. For any other use of this material please apply for a Click-Use PSI Licence or by writing to: Office of Public Sector Information Information Policy Team Kew Richmond Surrey TW9 4DU e-mail: [email protected] Information about this publication and copies are available from: Exotic Disease Policy Programme Defra Nobel House 17 Smith Square London SW1P 3JR This document is available on the Defra website: Published by the Department for Environment, Food and Rural Affairs Vaccination as a Control Tool for Exotic Animal Disease Key Considerations Introduction 4 Using Vaccination against an Exotic Animal Disease: Implications 5 and Considerations Veterinary and Technical Considerations 5 Whether vaccination is the most appropriate disease control tool 5 Box A: A disease for which vaccination is -
Bos Frontalis)
1599 Physical Feature, Physiological Character and Behavior Study of Gayal (Bos frontalis) M. Giasuddin* and M. R. Islam Animal Health Research Division, Bangladesh Livestock Research Institute, Savar, Dhaka-1341, Bangladesh ABSTRACT : The physical feature, physiological character and behavior studies were conducted with fifteen newly collected gayals in Bandarban hill tract area of Bangladesh. Their morphology is different from domestic cattle. The range of pulse rate, body temperature and respiration rate were 47 to 75 per minute, 37.78 to 38.88°C and 20 to 40 per minute, respectively. These physiological values vary with different age group and seasonal variation. In hematological feature, the average findings were RBC 7.01±0.52 million/cu.mm, WBC 14.3±3.69 thousand/cu.mm, hemoglobin concentration 9.81±2.25 gm%, PCV 35.86±3.68%. In differential WBC count neutrophils 28.23±1.75 %, lymphocytes 62±2.05 %, monocytes 4.4±1.34%, eosinophils 5±2.49% and basophils 0.4±0.51%. In behavior study, the animal shows browsing nature on hill slopes. They are watchful in new environment, become excited and nervous with strangers. Heated female gayals response for mating with domestic bull. (Asian-Aust. J. Anim. Sci. 2003. Vol 16, No. 11 : 1599- 1603) Key Words : Physical Feature, Physiological Character, Behavior, Gayal INTRODUCTION Bandarban hill tract area of Bangladesh Livestock Research Institute. The station is located Southeastern hilly parts of The gayal belongs to the family Bovidae, tribe Bovini, Bangladesh and about 20 meter above the sea level. The group Bovina, genus Bos and species Bos frontalis, is very land type is high land with strong acidic (pH 4.5 to 4.9) much related with the Indian Bison. -
Report on Bovine Herpesvirus 1 (BHV1)
Sanco/C3/AH/R20/2000 EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Scientific Opinions &ÃÃ0DQDJHPHQWÃRIÃVFLHQWLILFÃFRPPLWWHHVÃ,,ÃVFLHQWLILFÃFRRSHUDWLRQÃDQGÃQHWZRUNV 5HSRUWRQ %RYLQH+HUSHVYLUXV %+9 PDUNHUYDFFLQHV DQGWKHDFFRPSDQ\LQJ GLDJQRVWLFWHVWV 6FLHQWLILF&RPPLWWHHRQ$QLPDO+HDOWKDQG$QLPDO:HOIDUH $GRSWHG2FWREHU 5HSRUWRQ %RYLQH+HUSHVYLUXV %+9 PDUNHUYDFFLQHVDQGWKH DFFRPSDQ\LQJGLDJQRVWLFWHVWV 6FLHQWLILF&RPPLWWHHRQ$QLPDO+HDOWKDQG$QLPDO:HOIDUH 6&$+$: &RQWHQWV 5(48(67)25$123,1,21 ,1752'8&7,21$1'%$&.*5281' ',6&866,21211(:'$7$210$5.(59$&&,1(6$1'7+(,5,03/,&$7,216)25 %+9(5$',&$7,21 3.1. TYPES OF MARKER VACCINES AND THEIR POSSIBLE USE IN THE EUROPEAN UNION ..........................................3 3.2. EFFICACY OF MARKER VACCINES FOR USE IN ERADICATION PROGRAMMES ......................................................3 ([SHULPHQWDOVWXGLHV )LHOGWULDOV 'LVFXVVLRQDQGFRQFOXVLRQ 3.3 SAFETY, RISKS OF LATENCY, REACTIVATION, RE-EXCRETION, TRANSMISSION AND RECOMBINATION ASSOCIATED WITH THE USE OF LIVE MARKER VACCINES ............................................................................................7 ([SHULPHQWDOVWXGLHV 'LVFXVVLRQDQGFRQFOXVLRQ 3.4. QUALITY OF THE AVAILABLE ACCOMPANYING DIAGNOSTIC TESTS..................................................................9 7HVW6HQVLWLYLW\DQG6SHFLILFLW\ 5HSURGXFLELOLW\ 'LVFXVVLRQ 3.5 POSSIBILITY OF THE EXISTENCE OF SERONEGATIVE CARRIERS AND THE RISKS POSED.....................................11 ([SHULPHQWDOGDWD 'LVFXVVLRQDQGFRQFOXVLRQ *(1(5$/&21&/86,21 -
A Decade of Research Into Classical Swine Fever
Blome et al. Vet Res (2017) 48:51 DOI 10.1186/s13567-017-0457-y REVIEW Open Access A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties Sandra Blome*, Kerstin Wernike, Ilona Reimann, Patricia König, Claudia Moß and Martin Beer Abstract Due to its impact on animal health and pig industry, classical swine fever (CSF) is still one of the most important viral diseases of pigs. To control the disease, safe and highly efcacious live attenuated vaccines exist for decades. However, until recently, the available live vaccines did not allow a serological marker concept that is essentially important to circumvent long-term trade restrictions. In 2014, a new live attenuated marker vaccine, Suvaxyn ® CSF Marker (Zoetis), was licensed by the European Medicines Agency. This vaccine is based on pestivirus chimera “CP7_E2alf” that car- ries the main immunogen of CSF virus “Alfort/187”, glycoprotein E2, in a bovine viral diarrhea virus type 1 backbone (“CP7”). This review summarizes the available data on design, safety, efcacy, marker diagnostics, and its possible integration into control strategies. Table of contents in either endemic situations or in case of large, high- 1 Introduction impact contingencies, safe and highly efcacious live 2 Design and manufacturing attenuated vaccines exist for decades [50]. Te under- lying virus strains (e.g. the C-strain of CSFV or the 3 Genetic stability guinea-pig exaltation negative GPE−-strain) were 4 Safety and vaccine virus distribution attenuated through serial passages in either animals 5 Efcacy (rabbits) or cell culture, and have been implemented 6 Diva as part of mandatory control programs that led to the 6.1 Genetic DIVA eradication of CSF from several countries [19]. -
(PRNP) in Gayal (Bos Frontalis) Sameeullah Memon
Research Article Deletion/insertion polymorphisms of the prion protein gene (PRNP) in Gayal (Bos frontalis) Sameeullah Memon†, Guozhi Li†, Heli Xiong†, Liping Wang†, Xiangying Liu†, Mengya Yuan†, Weidong Deng†, Dongmei Xi†,※ † Yunnan Provincial Key Laboratory of Animal Nutrition and Feed Science, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming 650201, China ※ Corresponding author: Dongmei Xi, Associate Professor, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming 650201, China E-mail: [email protected] Running head: Polymorphisms of the prion protein gene (PRNP) in Gayal Abstract Resistance to the fatal disease bovine spongiform encephalopathy (BSE), due to miss folded prion protein in cattle, is associated with a 23 bp indel polymorphism in the putative promoter and a 12 bp indel in intron 1 of the PRNP gene. The Gayal (Bos frontalis) is an important semi- wild bovid species and of great conservation concern, but so far these indel polymorphisms have not been evaluated in Gayal animals. Therefore we collected samples of 225 Gayals and evaluated the genetic indel polymorphism in the two regions of this PRNP gene. The results revealed high allelic frequencies of insertions at these indel sites: 0.909 and 0.667 for respectively the 23 bp and 12 bp indels, both also with significant genotype frequencies (χ2-9.81; 23 bp and χ2-43.56; 12 bp). At the same time, the haplotype data showed indel polymorphisms with extremely low deletion (0.01) in both regions of the PRNP gene. We compared these data with those reported for healthy and BSE affected cattle (Bos taurus) breeds from two European countries, Germany and Switzerland, and significant difference (p<0.001) was observed from BSE affected as well as the healthy cattle. -
CATAIR Appendix
CBP and Trade Automated Interface Requirements Appendix: PGA October 8, 2020 Pub # 0875-0419 Contents Table of Changes .................................................................................................................................................... 4 PG01 – Agency Program Codes ........................................................................................................................... 18 PG01 – Government Agency Processing Codes ................................................................................................... 22 PG01 – Electronic Image Submitted Codes.......................................................................................................... 26 PG01 – Globally Unique Product Identification Code Qualifiers ........................................................................ 26 PG01 – Correction Indicators* ............................................................................................................................. 26 PG02 – Product Code Qualifiers........................................................................................................................... 28 PG04 – Units of Measure ...................................................................................................................................... 30 PG05 – Scientific Species Code ........................................................................................................................... 31 PG05 – FWS Wildlife Description Codes ........................................................................................................... -
COX BRENTON, a C I Date: COX BRENTON, a C I USDA, APHIS, Animal Care 16-MAY-2018 Title: ANIMAL CARE INSPECTOR 6021 Received By
BCOX United States Department of Agriculture Animal and Plant Health Inspection Service Insp_id Inspection Report Customer ID: ALVIN, TX Certificate: Site: 001 Type: FOCUSED INSPECTION Date: 15-MAY-2018 2.40(b)(2) DIRECT REPEAT ATTENDING VETERINARIAN AND ADEQUATE VETERINARY CARE (DEALERS AND EXHIBITORS). ***In the petting zoo, two goats continue to have excessive hoof growth One, a large white Boer goat was observed walking abnormally as if discomforted. ***Although the attending veterinarian was made aware of the Male Pere David's Deer that had a front left hoof that appeared to be twisted approximately 90 degrees outward from the other three hooves and had a long hoof on the last report, the animal has not been assessed and a treatment pan has not been created. This male maneuvers with a limp on the affect leg. ***A female goat in the nursery area had a large severely bilaterally deformed udder. The licensee stated she had mastitis last year when she kidded and he treated her. The animal also had excessive hoof length on its rear hooves causing them to curve upward and crack. The veterinarian has still not examined this animal. Mastitis is a painful and uncomfortable condition and this animal has a malformed udder likely secondary to an inappropriately treated mastitis. ***An additional newborn fallow deer laying beside an adult fallow deer inside the rhino enclosure had a large round spot (approximately 1 1/2 to 2 inches round) on its head that was hairless and grey. ***A large male Watusi was observed tilting its head at an irregular angle. -
ACE Appendix
CBP and Trade Automated Interface Requirements Appendix: PGA August 13, 2021 Pub # 0875-0419 Contents Table of Changes .................................................................................................................................................... 4 PG01 – Agency Program Codes ........................................................................................................................... 18 PG01 – Government Agency Processing Codes ................................................................................................... 22 PG01 – Electronic Image Submitted Codes .......................................................................................................... 26 PG01 – Globally Unique Product Identification Code Qualifiers ........................................................................ 26 PG01 – Correction Indicators* ............................................................................................................................. 26 PG02 – Product Code Qualifiers ........................................................................................................................... 28 PG04 – Units of Measure ...................................................................................................................................... 30 PG05 – Scientific Species Code ........................................................................................................................... 31 PG05 – FWS Wildlife Description Codes ........................................................................................................... -
Farm-Vaccine-Long.Pdf
GUIDELINES Responsible use of vaccines and vaccinations in farm animal production A farm health planning initiative in partnership with DEFRA Supported by the National Office of Animal Health (NOAH) November 2006 CONTENTS Page No. CONTENTS........................................................................................................................1 INTRODUCTION.............................................................................................................. 3 THE MECHANISMS OF INFECTION AND IMMUNITY ......................................... 4 Defence Mechanisms.......................................................................................................... 4 IMMUNITY........................................................................................................................5 Humoral (or [Blood] Circulating) Immunity .................................................................. 6 Cell Mediated Immunity (CMI) ....................................................................................... 7 THE OBJECTIVES OF VACCINATION ...................................................................... 8 TYPES OF ANTIBODY.................................................................................................... 8 THE PROCESS OF PRODUCING AN IMMUNE RESPONSE.................................. 8 Vaccines ............................................................................................................................ 10 Reactivation of the Immune Response..........................................................................